English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/219726
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Tryptophan trimers and tetramers inhibit dengue and Zika virus replication by interfering with viral attachment processes

AuthorsFikatas, A.; Vervaeke, P.; Martínez-Gualda, Belén; Martí-Marí, Olaia; Noppen, S.; Meyen, E.; Camarasa Rius, María José ; San-Félix, Ana ; Pannecouque, C.; Schols, D.
KeywordsSPR, Zika, antivirals, dengue, envelope protein, virus attachme
Issue Date2020
PublisherAmerican Society for Microbiology
CitationAntimicrobial Agents and Chemotherapy 64 (2020)
AbstractHere, we report a class of tryptophan trimers and tetramers that inhibit (at low micromolar range) dengue and Zika virus infection in vitro. These compounds (AL family) have three or four peripheral tryptophan moieties directly linked to a central scaffold through their amino groups; thus, their carboxylic acid groups are free and exposed to the periphery. Structure-activity relationship (SAR) studies demonstrated that the presence of extra phenyl rings with substituents other than COOH at the N1 or C2 position of the indole side chain is a requisite for the antiviral activity against both viruses. The molecules showed potent antiviral activity, with low cytotoxicity, when evaluated on different cell lines. Moreover, they were active against laboratory and clinical strains of all four serotypes of dengue virus as well as a selected group of Zika virus strains. Additional mechanistic studies performed with the two most potent compounds (AL439 and AL440) demonstrated an interaction with the viral envelope glycoprotein (domain III) of dengue 2 virus, preventing virus attachment to the host cell membrane. Since no antiviral agent is approved at the moment against these two flaviviruses, further pharmacokinetic studies with these molecules are needed for their development as future therapeutic/prophylactic drugs.
Publisher version (URL)http://dx.doi.org/10.1128/AAC.02130-19
URIhttp://hdl.handle.net/10261/219726
Identifiersdoi: 10.1128/AAC.02130-19
issn: 1098-6596
Appears in Collections:(IQM) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.